About
Small molecule
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Team (16)
Alan Walts
Alan Walts, Ph.D.
Artax Biopharma
team_member
Andre Hoekema
Andre Hoekema, Ph.D.
Artax Biopharma
team_member
Andy Gagete
Andy Gagete, Ph.D.
Artax Biopharma
team_member
Balbino Alarcón
Balbino Alarcón, Ph.D
Artax Biopharma
team_member
Casper Breum
Casper Breum
Artax Biopharma
team_member
Chris VanDeusen
Chris VanDeusen, Ph.D.
Artax Biopharma
team_member
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
163
By Phase
PHASE1/PHASE2: 2PHASE1: 3
By Status
COMPLETED: 4RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT06550011Lead Sponsor
Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV)
PHASE1/PHASE2Recruiting
18 participants
Started: Aug 7, 2024 · Completed: Feb 28, 2030
NCT05725057Lead Sponsor
Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis
PHASE1/PHASE2Completed
31 participants
Started: Nov 30, 2023 · Completed: Oct 4, 2024
NCT05218434Lead Sponsor
A Study of the Safety, Tolerability, Pharmacokinetics and Food Effect After Single and Multiple Ascending Oral Doses
PHASE1Completed
64 participants
Started: Nov 17, 2021 · Completed: Dec 3, 2022
NCT02546635Lead Sponsor
Potential Food Effect And Repeated Dosing of AX-024.HCl In Healthy Subjects
PHASE1Completed
32 participants
Started: Aug 31, 2015 · Completed: Jan 31, 2016
NCT02243683Lead Sponsor
Safety Study of Immune System Modulator for Autoimmune Diseases
PHASE1Completed
18 participants
Started: Sep 30, 2014 · Completed: Mar 31, 2015
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...